Treatment with the PARP inhibitor, niraparib, sensitizes...

Cancer Cell International 2015 Vol. 15; Iss. 1

Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status

Genther Williams, Sybil M, Kuznicki, Apryle M, Andrade, Paula, Dolinski, Brian M, Elbi, Cem, O’Hagan, Ronan C, Toniatti, Carlo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Year:
2015
Language:
english
Journal:
Cancer Cell International
DOI:
10.1186/s12935-015-0162-8
File:
PDF, 1.75 MB
english, 2015
Conversion to is in progress
Conversion to is failed